Royse Kathryn E, Chen Liang, Berger David H, Ittmann Michael M, El-Serag Hashem B, Balentine Courtney J, Graham David Y, Richardson Peter A, Rumbaut Rolando E, Shen Xiaoyun, White Donna L, Jiao Li
Department of Medicine, Baylor College of MedicineHouston 77030, TX, USA.
Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E DeBakey VA Medical CenterHouston 77030, TX, USA.
Int J Mol Epidemiol Genet. 2017 Apr 15;8(2):8-18. eCollection 2017.
Toll-like receptors (TLRs) and the receptor for advanced glycation end products (AGER) are pattern recognition receptors that regulate intestinal inflammatory homeostasis. However, their relevance in colorectal cancer (CRC) prognosis is unclear. We investigated expression of , , and interacting proteins in association with CRC mortality in a retrospective cohort study of 65 males diagnosed with primary resectable CRC between 2002 and 2009. Multiplex quantitative nuclease protection assay was used to quantify the expression of 19 genes in archived tissues of tumor and paired adjacent normal mucosa. We evaluated the association between log2 (tumor/normal) expression ratios for single and combined genes and all-cause mortality using multivariable Cox regression analysis. The false discovery rate adjusted -value less than 0.10 indicated statistical significance for single gene. Five-year survival time was calculated from diagnosis of CRC to death, lost to follow-up, or December 31, 2014. Compared to paired normal mucosa, expression levels of , , , and were lower ( = 0.0002); while and were higher ( = 0.0002) in tumor epithelia. Higher tumor expression of (HR = 0.68, 95% CI: 0.49-0.94), (HR = 0.70, 95% CI: 0.52-0.94), (HR = 0.53, 95% CI: 0.30-0.93), and (HR = 0.71, 95% CI: 0.52-0.98) was associated with higher mortality risk. There was a synergistic effect on lower five-year survival in lower co-expressers of and ( < 0.0001). Our findings suggest that a TLRs/MyD88-mediated inflammatory response may play a role in CRC prognosis. The role of pattern recognition receptor-mediated immunity in CRC mortality warrants further research.
Toll样受体(TLRs)和晚期糖基化终产物受体(AGER)是调节肠道炎症稳态的模式识别受体。然而,它们在结直肠癌(CRC)预后中的相关性尚不清楚。在一项对2002年至2009年间诊断为原发性可切除CRC的65名男性进行的回顾性队列研究中,我们调查了[具体基因名称未给出]及其相互作用蛋白的表达与CRC死亡率的关系。采用多重定量核酸酶保护分析法定量肿瘤存档组织和配对的相邻正常黏膜中19个基因的表达。我们使用多变量Cox回归分析评估单个和组合基因的log2(肿瘤/正常)表达比值与全因死亡率之间的关联。错误发现率调整后的P值小于0.10表明单个基因具有统计学意义。从CRC诊断到死亡、失访或2014年12月31日计算五年生存时间。与配对的正常黏膜相比,肿瘤上皮中[具体基因名称未给出]、[具体基因名称未给出]、[具体基因名称未给出]和[具体基因名称未给出]的表达水平较低(P = 0.0002);而[具体基因名称未给出]和[具体基因名称未给出]较高(P = 0.0002)。肿瘤中[具体基因名称未给出](HR = 0.68,95%CI:0.49 - 0.94)、[具体基因名称未给出](HR = 0.70,95%CI:0.52 - 0.94)、[具体基因名称未给出](HR = 0.53,95%CI:0.30 - 0.93)和[具体基因名称未给出](HR =